Form 8-K - Current report:
SEC Accession No. 0001792044-21-000023
Filing Date
2021-08-09
Accepted
2021-08-09 08:31:01
Documents
14
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtrs-20210809.htm   iXBRL 8-K 32035
2 EX-99.1 exhibit991-2q21earningsrel.htm EX-99.1 552424
  Complete submission text file 0001792044-21-000023.txt   764686

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtrs-20210809.xsd EX-101.SCH 2178
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtrs-20210809_def.xml EX-101.DEF 3337
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtrs-20210809_lab.xml EX-101.LAB 29108
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtrs-20210809_pre.xml EX-101.PRE 16346
7 EXTRACTED XBRL INSTANCE DOCUMENT vtrs-20210809_htm.xml XML 8543
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 211154767
SIC: 2834 Pharmaceutical Preparations